In vivo CRO refers to the preclinical testing performed for preclinical testing of disease pathology and drug discovery. In vivo CROs provide information regarding the collection and investigation of data for the development of new drugs for the treatment of various indications such as diabetes, cancer, autoimmune disorders, and others.
MARKET DYNAMICS
The in vivo CRO market is anticipated to grow in the forecast, owing to rising price competition and requirement to reduce cost coupled with a rise in the demand for advanced products. In addition, changing regulatory policies and the increase in chronic medical conditions is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "In Vivo CRO Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in vivo CRO market with detailed market segmentation by specimen type, study type, indication, and geography. The in vivo CRO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in vivo CRO market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The in vivo CRO market is segmented on the basis of specimen type, study type and indication. Based on specimen type the market is segmented as, rodent and non-rodent. On the basis of study type the market is categorized as, non GLP and GLP. Also, based on indication, the market is segmented as, autoimmune/ inflammatory conditions, pain management, oncology, CNS conditions, diabetes, obesity, and other indications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in vivo CRO market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The in vivo CRO market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting in vivo CRO market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the in vivo CRO market in these regions.
MARKET PLAYERS
The report covers key developments in the in vivo CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in vivo CRO market are anticipated to have lucrative growth opportunities in the future with the rising demand for in vivo CRO market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.
The report also includes the profiles of key in vivo CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- American Preclinical Services, LLC.
- Charles River
- Covance Inc.
- GVK Biosciences Private Limited
- Iris Pharma
- MELIOR DISCOVERY
- Pronexus Analytical AB
- Syneos Health
- Washington Biotechnology, Inc.
- WuXi AppTec